Cef-3 DS: An Oral Cephalosporin Antibiotic

Cef-3 DS is an orally active, third-generation cephalosporin antibiotic. It demonstrates significant bactericidal activity against a wide range of Gram-positive and Gram-negative organisms. It is indicated for the treatment of various acute infections caused by susceptible microorganisms.

How Cef-3 DS Works (Pharmacology)

Cef-3 DS contains Cefixime, which is a semisynthetic cephalosporin antibiotic. It kills bacteria by interfering with the synthesis of their bacterial cell wall. This disruption leads to the weakening and eventual lysis (bursting) of the bacterial cell, thus eradicating the infection. Cefixime is highly stable in the presence of Beta-lactamase enzymes, which are produced by some bacteria to break down antibiotics like penicillins and some cephalosporins. This stability means that many organisms resistant to other antibiotics due to beta-lactamase production may still be susceptible to Cefixime. Approximately 40% to 50% of an oral dose is absorbed, regardless of whether it's administered with or without food.

Key Indications & Benefits

Cef-3 DS is used for the treatment of acute infections, including:

• Upper Respiratory Tract Infections (URTI): Such as otitis media (middle ear infection), and other URTI where the causative organism is known or suspected to be resistant to commonly used antibiotics, or where treatment failure poses a significant risk.
• Lower Respiratory Tract Infections (LRTI): For example, bronchitis.
• Urinary Tract Infections (UTI): Including cystitis, cystourethritis, and pyelonephritis.

Clinical efficacy has been demonstrated against common pathogens such as Streptococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (both beta-lactamase positive and negative), Moraxella catarrhalis (both beta-lactamase positive and negative), and Enterobacter species.

Dosage & Administration

The absorption of Cefixime is not significantly affected by food. The usual course of treatment is 7 days, but it may be continued for up to 14 days if required.

• Adults and children over 10 years: The recommended adult dosage is 200-400 mg daily, depending on the severity of the infection. This can be given either as a single dose or in two divided doses.
• Elderly: Elderly patients can be given the same dose as adults. However, renal function should be assessed, and the dosage should be adjusted in cases of severe renal impairment.
• Children: The recommended dosage for children is 8 mg/kg/day, administered as a single dose or in two divided doses.
  • Suspension dosing guide:
    • 6 months up to 1 year: 3.75 ml daily
    • Children 1-4 years: 5 ml daily
    • Children 5-10 years: 10 ml daily
  • In Typhoid: The recommended children's dose is 5 mg/kg body weight twice daily for 10-14 days.
  • Children weighing more than 50 kg or older than 10 years: Should be treated with the recommended adult dose (200-400 mg daily depending on the severity of infection).
  • Children aged less than 6 months: The safety and efficacy of Cefixime have not been established.
• Dosage in Renal Impairment: Cefixime can be administered with impaired renal function.
  • For patients with creatinine clearances of 20 ml/min or greater: Normal dose and schedule can be given.
  • For patients with creatinine clearance less than 20 ml/min: A dose of 200 mg once daily should not be exceeded.
  • Patients on chronic ambulatory peritoneal dialysis or hemodialysis: Should follow the same recommendation as for patients with creatinine clearances of less than 20 ml/min.

Always consult a registered physician for medication use.

Important Considerations & Warnings

It is crucial to discuss your full medical history with your doctor before taking Cef-3 DS.

Contraindications:

• Patients with known hypersensitivity to cephalosporin antibiotics.

Side Effects: Cef-3 DS is generally well tolerated, with most adverse reactions being mild and self-limiting.

• Gastrointestinal disturbances (most frequent): Diarrhea and stool changes (more common with higher doses), nausea, abdominal pain, dyspepsia, vomiting, and flatulence.
• Pseudomembranous colitis has been reported (a more severe form of diarrhea).
• Central Nervous System: Headache and dizziness.
• Hypersensitivity reactions (rare): Rash, pruritus (itching), urticaria (hives), drug fever, and arthralgia (joint pain). These usually subside upon discontinuation of therapy.
• Hematological and Clinical Chemistry (infrequent and reversible): Thrombocytopenia (low platelets), leukopenia (low white blood cells), and eosinophilia (increased eosinophils). Mild transient changes in liver and renal function tests.
• Miscellaneous: Genital pruritus and vaginitis.

Interactions:

• Anticoagulants (e.g., Warfarin): Increases in prothrombin times have been noted in a few patients. Care should be taken in patients receiving anticoagulant therapy, and monitoring may be necessary.

Pregnancy & Lactation:

• Pregnancy: There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed and considered essential by the physician, as animal reproduction studies are not always predictive of human response.
• Lactation: It is not known whether Cefixime is excreted in human milk. Caution should be exercised, and use in nursing mothers is generally not recommended unless considered essential by the physician.

Precautions & Warnings:

• Hypersensitivity: Administer with caution to patients who have shown hypersensitivity to other drugs.
• Penicillin Sensitivity: Cephalosporins should be given with caution to penicillin-sensitive patients due to evidence of partial cross-allergenicity between penicillins and cephalosporins. Severe reactions (including anaphylaxis) have occurred with both classes of drugs. If an allergic effect occurs with Cef-3 DS, discontinue the drug and treat the patient appropriately.
• Renal Impairment: Administer with caution in patients with markedly impaired renal function; dosage adjustments are necessary.
• Antibiotic-Associated Diarrhea: Treatment with broad-spectrum antibiotics can alter normal colon flora, potentially leading to overgrowth of Clostridium difficile and antibiotic-associated diarrhea (including pseudomembranous colitis).

Overdose Effects:

• In the event of an overdose, gastric lavage may be indicated. No specific antidote exists.
• Cef-3 DS is not removed in significant quantities by hemodialysis or peritoneal dialysis.
• Adverse reactions from single doses up to 2 g in healthy volunteers did not differ from the profile seen at recommended doses.

Storage Conditions

Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.